234 related articles for article (PubMed ID: 24060154)
21. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
[TBL] [Abstract][Full Text] [Related]
22. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
23. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
Mainenti M; Rasotto R; Carnier P; Zappulli V
Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
[TBL] [Abstract][Full Text] [Related]
24. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
25. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
26. Expression of cyclooxygenase-2 in neoplasms of the mammary gland in bitches.
Badowska-Kozakiewicz AM; Malicka E
Pol J Vet Sci; 2010; 13(2):337-42. PubMed ID: 20731190
[TBL] [Abstract][Full Text] [Related]
27. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.
Shiomitsu K; Johnson CL; Malarkey DE; Pruitt AF; Thrall DE
Vet Comp Oncol; 2009 Jun; 7(2):106-14. PubMed ID: 19453364
[TBL] [Abstract][Full Text] [Related]
28. COX-2 expression in canine normal and neoplastic mammary gland.
Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
[TBL] [Abstract][Full Text] [Related]
29. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
30. Myoepithelial cell layer integrity in canine mammary carcinoma.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
[TBL] [Abstract][Full Text] [Related]
31. Expression of Oxytocin Receptors in Canine Mammary Tumours.
Benavente MA; Bianchi CP; Aba MA
J Comp Pathol; 2019 Jul; 170():26-33. PubMed ID: 31375156
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
Rodo A; Malicka E
Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
[TBL] [Abstract][Full Text] [Related]
34. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of tumour-associated macrophages in canine mammary tumours.
Raposo T; Gregório H; Pires I; Prada J; Queiroga FL
Vet Comp Oncol; 2014 Mar; 12(1):10-9. PubMed ID: 22533625
[TBL] [Abstract][Full Text] [Related]
36. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
37. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
[TBL] [Abstract][Full Text] [Related]
39. Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.
Delgado L; Gärtner F; Dias Pereira P
J Comp Pathol; 2015; 152(2-3):138-44. PubMed ID: 25670666
[TBL] [Abstract][Full Text] [Related]
40. CD204-Expressing Tumor-Associated Macrophages Are Associated With Malignant, High-Grade, and Hormone Receptor-Negative Canine Mammary Gland Tumors.
Seung BJ; Lim HY; Shin JI; Kim HW; Cho SH; Kim SH; Sur JH
Vet Pathol; 2018 May; 55(3):417-424. PubMed ID: 29343199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]